FDG-PET for hepatobiliary and pancreatic cancer: Advances and current limitations

doi:10.5306/wjco.v2.i5.229

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 2, Issue 5

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4913)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-11) series.

Item

Count

PDF

404

HTML

4174

Figures (1-11)

335

Sum=4913

May 10, 2011 (publication date) through Nov 7, 2024

Times Cited of This Article

Times Cited (25)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Clin Oncol. May 10, 2011; 2(5): 229-236
Published online May 10, 2011. doi: 10.5306/wjco.v2.i5.229

FDG-PET for hepatobiliary and pancreatic cancer: Advances and current limitations

Koji Murakami

Koji Murakami, Division of Nuclear Medicine, Department of Radiology , School of Medicine, Keio University, 35 Shinanomachi, Shinjyuku-ku, 160-8582 Tokyo, Japan

Author contributions: Murakami K solely contributed to this paper.

Correspondence to: Koji Murakami, Professor, Division of Nuclear Medicine, Department of Radiology , School of Medicine, Keio University, 35 Shinanomachi, Shinjyuku-ku, 160-8582 Tokyo, Japan. kjmuraka@z3.keio.jp

Telephone: +81-3-33531211-64446 Fax: +81-3-33531977

Received: January 24, 2011
Revised: March 8, 2011
Accepted: March 15, 2011
Published online: May 10, 2011

Core Tip